Cryoport, Inc. (CYRX) Cash Flow Statement
Cryoport, Inc. (CYRX) generated $8.0M of operating cash flow over the twelve months to 2026-06-30, spent $28.2M on capital expenditure and had free cash flow of -$20.2M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CYRXCryoport, Inc.Follow CYRX — free
—
Price chart with a free account
- Market cap
- 910.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2012 Mar 12 | FY2013 Mar 13 | FY2014 Mar 14 | FY2015 Mar 15 | FY2016 Mar 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.01 | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 | -0.01 | 0.01 | -0.00 | -0.00 | -0.02 | -0.01 | 0.01 | |
| Capital expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | — | 0.02 | 0.02 | 0.04 | 0.02 | 0.02 | -0.03 | |
| Free cash flow | -0.01 | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | — | -0.02 | -0.03 | -0.04 | -0.04 | -0.03 | -0.02 | |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | 0.04 | — | — | 0.01 | — | |
| Stock-based compensation | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | — | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | — |
USD billions · SEC XBRL
Cryoport, Inc. — questions
- What is Cryoport, Inc.'s operating cash flow?
- $8.0M over the twelve months to 2026-06-30.
- How much does Cryoport, Inc. spend on capital expenditure?
- $28.2M over the twelve months to 2026-06-30.
- What is Cryoport, Inc.'s free cash flow?
- -$20.2M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Cryoport, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.